Epitomee Medical Ltd develops and commercializes ingestible therapeutic devices in Israel. The company offers capsules for the treatment of overweight and obesity. It also focuses on developing biologic drug delivery solutions. Epitomee Medical Ltd was incorporated in 2005 and is based in Caesarea, Israel.
Frequently asked questions
What sector does Epitomee Medical Ltd (EPIT) operate in?
Epitomee Medical Ltd belongs to the Healthcare sector and operates in the Medical Devices industry.
What is Epitomee Medical Ltd (EPIT) current stock price?
As of the latest data, Epitomee Medical Ltd stock price is ₪3.84, with a previous close of ₪3.63. Epitomee Medical Ltd gained ₪0.21 in the last trading session, representing a 5.73% increase.
What is Epitomee Medical Ltd (EPIT) current market capitalization?
Epitomee Medical Ltd market cap is approximately 115.66 million.
What is Epitomee Medical Ltd (EPIT) Earnings Per Share (EPS)?
The trailing EPS is -₪0.89.
Does Epitomee Medical Ltd (EPIT) pay dividends?
No. Epitomee Medical Ltd does not pay a dividend.
What is Epitomee Medical Ltd (EPIT) beta (volatility) score?
Epitomee Medical Ltd has a beta of 0.433, indicating lower volatility than the overall market.